The recent revelation that Eli Lilly used ghostwriters to write favorable articles on the use of Zyprexa and sought out physicians to put their names on the respective papers brings up the issue of the common practice of medical writers [...] ...
I really like the term "disrupt". I especially like it in the true way that it was meant to be used when we talk about marketing. I do fear that this powerful word, and even more powerful concept, [...] ...
The FDA recently published their draft guidance for DTC advertising. The document, titled "Presenting Risk Information on Prescription Drug and Medical Device Promotion," proposes that marketers use a reasonable consumer standard, similar to the FTC standard, to determine whether [...] ...
What a crappy time to be a salesperson. It feels like they have everything against them right now. At the retail level people just aren't spending — or don't have the money they used to. [...] ...
We have all been affected in some way by deregulation and the current mess that is Wall Street and the banking industry. More and more, it seems like there can never be a balanced approach to societal behavior [...] ...
All eyes are on Twitter as both the company itself and legions of salivating marketers try to figure out just what advertising will look like on the hot microblogging site. Of course, advertising is nothing new to Twitter [...] ...
Speakers' training meetings are conferences organized by pharmaceutical or device manufacturers, designed to bring together and train a group of key opinion leaders on the company’s product or disease state so they can speak at various events organized by either the company of medical associations. ...
Nothing great has been discovered without taking risks... Fabulous failures tend to generate phenomenal innovations. So why, in an era where we value innovations, do we no longer take risks? [...] ...